Important notice

Labour dispute at Canada Post

We have put in place measures to mitigate the impact on our clients.

Gouvernement du Québec
Régie de l’assurance maladie

Important information

The contents of this webpage are in French only.

Find out whether a drug is covered

Over 8,000 prescription drugs are covered under the Public Prescription Drug Insurance Plan. They are included on a regularly updated list. Other drugs not on the list may also be covered on an exceptional basis.

Prescription drug search

Disclaimer : Search results do not have the same value as a legal document. To access the relevant legal document, please refer to the List of Medications.

4762 results found.

Example of search result explained

Alfuzosin

Covered
  • Active ingredient(s):
    alfuzosine hydrochloride
  • Manufactured by:
    Sivem Produits Pharmaceutiques ULC (Sivem)
  • Strength and dosage form:
    Long-Action Tablet 10 mg DIN : 2447576

Apo-Alfuzosin

Covered
  • Active ingredient(s):
    alfuzosine hydrochloride
  • Manufactured by:
    Apotex Inc. (Apotex)
  • Strength and dosage form:
    Long-Action Tablet 10 mg DIN : 2315866

Auro-Alfuzosin

Covered
  • Active ingredient(s):
    alfuzosine hydrochloride
  • Manufactured by:
    Auro Pharma Inc. (AuroPharma)
  • Strength and dosage form:
    Long-Action Tablet 10 mg DIN : 2443201

Sandoz Alfuzosin

Covered
  • Active ingredient(s):
    alfuzosine hydrochloride
  • Manufactured by:
    Sandoz Canada Inc (Sandoz)
  • Strength and dosage form:
    Long-Action Tablet 10 mg DIN : 2304678

Xatral

Covered
  • Active ingredient(s):
    alfuzosine hydrochloride
  • Manufactured by:
    Sanofi-Aventis Canada Inc. (SanofiAven)
  • Strength and dosage form:
    Long-Action Tablet 10 mg DIN : 2245565

Myozyme

Exceptional medication
  • Active ingredient(s):
    alglucosidase alfa
  • Manufactured by:
    Genzyme Canada, une division de Sanofi-Aventis (Genzyme)
  • Strength and dosage form:
    Intravenous or Perfusion Powder 50 mg DIN : 2284863

Praluent (pen)

Exceptional medication
  • Active ingredient(s):
    alirocumab
  • Manufactured by:
    Sanofi-Aventis Canada Inc. (SanofiAven)
  • Strength and dosage form:
    • Subcutaneous Injectable Solution 150 mg/mL DIN : 2453835
    • Subcutaneous Injectable Solution 75 mg/mL DIN : 2453819

Hanzema

Exceptional medication
  • Active ingredient(s):
    alitretinoine
  • Manufactured by:
    Dr Reddy's Laboratories Canada Inc (Dr Reddy's)
  • Strength and dosage form:
    Capsule 30 mg DIN : 2477440

Toctino

Exceptional medication
  • Active ingredient(s):
    alitretinoine
  • Manufactured by:
    Janssen Inc. (Janss. Inc)
  • Strength and dosage form:
    Capsule 30 mg DIN : 2337649

Monovalent

Covered
  • Active ingredient(s):
    allergens (aqueous extracts of)
  • Manufactured by:
    Laboratoires Omega Ltée (Oméga)
  • Strength and dosage form:
    • Injectable Solution Maintenance Treatment (10 mL) DIN : 861227
    • Injectable Solution Maintenance Treatment (5 mL) DIN : 861170
    • Injectable Solution Complete Treatment Set (kit - 10 mL vials) DIN : 861138
    • Injectable Solution Complete Treatment Set (kit - 5 mL vials) DIN : 861073
Page 18 of 477

How did we do?

Was the information on this page useful to you?
Do not include any personal information. You will not receive any reply.